---
layout: page
title: "All publications since 2004"
meta_title: "Publications since 2004 - Verhaak Lab"
meta_description: "Chronological list of publications by Verhaak Lab since 2004"
permalink: "/all_publications/"
header:
#   image_fullwidth: "header_roadmap_2.jpg"
comments: false
show_meta: false
---
<div class="panel radius" markdown="1">
{: #toc }
*  TOC
{:toc}
</div>

#### 2015

Kim H, Zheng S, ..,Verhaak RG. Whole-genome and multisector exome sequencing of primary and post-treatment glioblastoma reveals patterns of tumor evolution. 
Genome Res.

<div id="up-to-top" class="row">
  <div class="small-12 columns" style="text-align: right;">
    <a style="text-align: right;" href="#top-of-page" title="Top of the page" alt="Top of the page"><i class="fa fa-chevron-circle-up fa-2x"></i></a>
  </div><!-- /.small-12.columns -->
</div><!-- /.row -->

#### 2014

Yoshihara, K. and Verhaak RG. Hiding in the dark: uncovering cancer drivers through image-guided genomics. 
Genome Biology.

Yoshihara, K. Wang Q, .., Verhaak RG. The landscape and therapeutic relevance of cancer-associated transcript fusions. 
Oncogene.

Cancer Genome Atlas Research Network. Integrated genomic characterization of papillary thyroid carcinoma. 
Cell.

Colen R, Foster I, .., Verhaak R, Whitman G. NCI Workshop Report: Clinical and Computational Requirements for Correlating Imaging Phenotypes with Genomics Signatures. 
Translational Oncology.

Galvao R, Kasina A, McNeill RS, et al. Transformation of quiescent adult oligodendrocyte precursor cells into malignant glioma through a multistep reactivation process. 
PNAS.

van Thuijl, H. F., I. Scheinin, D. Sie, et al. Spatial and temporal evolution of distal 10q deletion, a prognostically unfavorable event in diffuse low-grade gliomas. 
Genome Biology.

Qiao, Y., A. R. Quinlan, A. A. Jazaeri, et al. SubcloneSeeker: a computational framework for reconstructing tumor clone structure for cancer variant interpretation and prioritization. 
Genome Biology.

Hoadley KA, Yau C, Wolf DM, et al. Multiplatform analysis of 12 cancer types reveals molecular classification within and across tissues of origin. 
Cell.

Martinez E, Yoshihara, .., Verhaak RG. Comparison of gene expression patterns across 12 tumor types identifies a cancer supercluster characterized by TP53 mutations and cell cycle defects. 
Oncogene.

Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. 
Nature.

Han L, Yuan Y, .., Verhaak RG, Liang H. The Pan-Cancer analysis of pseudogene expression reveals biologically and clinically relevant tumour subtypes. 
Nature Communications.

Akbani R, Ng, H, Werner, M. et al. A pan-cancer proteomic perspective on The Cancer Genome Atlas. 
Nature Communications.

Torres-Garcia W, Zheng S, ..,Verhaak RG. PRADA: pipeline for RNA sequencing data analysis. 
Bioinformatics.

Zheng S. Kim H, Verhaak RG. Silent mutations make some noise. 
Cell.

Guan X, Vengoechea J, ..,Verhaak RG, Barnholtz-Sloan JS. Molecular subtypes of glioblastoma are relevant to lower grade glioma. 
PLoS One.

Chudnovsky Y, Kim D, Zheng S, et al. ZFHX4 Interacts with the NuRD Core Member CHD4 and Regulates the Glioblastoma Tumor-Initiating Cell State. 
Cell Reports.

<div id="up-to-top" class="row">
  <div class="small-12 columns" style="text-align: right;">
    <a style="text-align: right;" href="#top-of-page" title="Top of the page" alt="Top of the page"><i class="fa fa-chevron-circle-up fa-2x"></i></a>
  </div><!-- /.small-12.columns -->
</div><!-- /.row -->

#### 2013

Zheng S, Verhaak RG. Intragenic breakpoint: A marker of genome instability in glioblastoma. 
Cell Cycle.

Yoshihara K, Shahmoradgoli M, .., Verhaak RG. Inferring tumour purity and stromal and immune cell admixture from expression data. 
Nature Communications.

Brennan C, Verhaak RGW, McKenna A, et al. The Somatic Genomic Landscape of Glioblastoma. 
Cell.

The TCGA Research Network. The Cancer Genome Atlas Pan-Cancer analysis project.
Nature Genetics.

Saito N, Fu J, Zheng S, et al. A high Notch pathway activation predicts response to ? secretase inhibitors in proneural subtype of glioma tumor initiating cells.
Stem Cells.

Li J, Lu Y, Akbani R, et al. TCPA: a resource for cancer functional proteomics data.
Nature Methods.

Yang JY, Yoshihara K, ..,Verhaak RG. Predicting time to ovarian carcinoma recurrence using protein markers. 
Journal of Clinical Investigation.

Zheng S, Fu J, .., Verhaak RG. A survey of intragenic breakpoints in glioblastoma identifies a distinct subset associated with poor survival.
Genes and Development.

The TCGA Research Network. Comprehensive molecular characterization of clear cell renal cell carcinoma.
Nature.

Du Z, Fei T, Verhaak RG, et al. Integrative genomic analyses reveal clinically relevant long noncoding RNAs in human cancer.
Nat Struct Mol Biol.

Watanabe H, Francis JM, Woo MS, et al. Integrated cistromic and expression analysis of amplified NKX2-1 in lung adenocarcinoma identifies LMO3 as a functional transcriptional target.
Genes and Development.

Verhaak RG, Tamayo P, Yang JY, et al. Prognostically relevant gene expression signatures of high grade ovarian carcinoma. 
Journal of Clinical Investigation.
Perspective by GenomeWeb
Perspective by Nature Reviews Clinical Oncology

<div id="up-to-top" class="row">
  <div class="small-12 columns" style="text-align: right;">
    <a style="text-align: right;" href="#top-of-page" title="Top of the page" alt="Top of the page"><i class="fa fa-chevron-circle-up fa-2x"></i></a>
  </div><!-- /.small-12.columns -->
</div><!-- /.row -->

#### 2012

Verhaak RG, Mills GB. Regulation of mRNA expression in breast cancer - a cis-tematic trans-action. 
Breast Cancer Research.

Liang H, Cheung LW, Li J, et al. Whole-exome sequencing combined with functional genomics reveals novel candidate driver cancer genes in endometrial cancer. 
Genome Research

The TCGA Research Network. Comprehensive molecular portraits of human breast tumours. 
Nature.

Simpkins FA, Hevia-Paez P, Sun J, et al. Src inhibition with saracatinib reverses fulvestrant resistance in ER-positive ovarian cancer models in vitro and in vivo. 
Clinical Cancer Research.

Zong H, Verhaak RG, Canoll P. The cellular origin for malignant glioma and prospects for clinical advancements. 
Expert Reviews in Molecular Diagnostics.

Beekman R, Valkhof MG, Sanders MA, et al. Sequential gain of mutations in severe congenital neutropenia progressing to acute myeloid leukemia. 
Blood.

Koivunen P, Lee S, Duncan CG, et al. Transformation by the (R)-enantiomer of 2-hydroxyglutarate linked to EGLN activation. 
Nature.

Zheng S, Chheda MG, Verhaak RG. Studying a complex tumor: potential and pitfalls. 
The Cancer Journal.

<div id="up-to-top" class="row">
  <div class="small-12 columns" style="text-align: right;">
    <a style="text-align: right;" href="#top-of-page" title="Top of the page" alt="Top of the page"><i class="fa fa-chevron-circle-up fa-2x"></i></a>
  </div><!-- /.small-12.columns -->
</div><!-- /.row -->

#### 2011

Cho J, Pastorino S, Zeng Q, et al. Glioblastoma-derived epidermal growth factor receptor carboxyl-terminal deletion mutants are transforming and are sensitive to EGFR-directed therapies. 
Cancer Research.

Bass AJ, Lawrence MS, Brace LE, et al. Genomic sequencing of colorectal adenocarcinomas identifies a recurrent VTI1A-TCF7L2 fusion. 
Nature Genetics.

Liu C, Sage JC, Miller MR, et al. Mosaic analysis with double markers reveals tumor cell of origin in glioma. 
Cell.

The TCGA Research Network. Integrated genomic analyses of ovarian carcinoma. 
Nature.

Kostic AD, Ojesina AI, Pedamallu CS, et al. PathSeq: software to identify or discover microbes by deep sequencing of human tissue.

Winslow MM, Dayton TL, Verhaak RG, et al. Suppression of lung adenocarcinoma progression by Nkx2-1. 
Nature.

Wang XV, Verhaak RG, Purdom E, et al. Unifying gene expression measures from multiple platforms using factor analysis. 
PLoS One.

<div id="up-to-top" class="row">
  <div class="small-12 columns" style="text-align: right;">
    <a style="text-align: right;" href="#top-of-page" title="Top of the page" alt="Top of the page"><i class="fa fa-chevron-circle-up fa-2x"></i></a>
  </div><!-- /.small-12.columns -->
</div><!-- /.row -->

#### 2010

Noushmehr, H, Weisenberger, DJ, Diefes, K, et al. Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma. 
Cancer Cell.

Berger, MF, Levin, JZ, Vijayendran, K, et al. Integrative analysis of the melanoma transcriptome. 
Genome Research.

Verhaak RG, et al. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. 
Cancer Cell.
Press release with comments from Francis Collins, John Niederhuber and Eric Green
Nature News article
Listed as highly cited cancer paper by Nature Medicine

#### 2009

Verhaak RG, Wouters BJ, Erpelinck CA, et al.Prediction of molecular subtypes in acute myeloid leukemia based on gene expression profiling. 
Haematologica.

Verhaak RG, and Valk, PJ. Genes predictive of outcome and novel molecular classification schemes in adult acute myeloid leukemia. 
Cancer Treatment Research.

Sos, ML, Michel, K, Zander, T, et al.. Predicting drug susceptibility of non-small cell lung cancers based on genetic lesions. 
Journal of Clinical Investigation.

Bass, AJ, Watanabe, H, Mermel, CH, et al. SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas. 
Nature Genetics.

#### 2008

Shedden, K, Taylor, JM, Enkemann, SA, et al. Gene expression-based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study. 
Nature Medicine.

Sanders, MA, Verhaak RG, Geertsma-Kleinekoort, WM, et al. SNPExpress: integrated visualization of genome-wide genotypes, copy numbers and gene expression levels. 
BMC Genomics.

The Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. 
Nature.

<div id="up-to-top" class="row">
  <div class="small-12 columns" style="text-align: right;">
    <a style="text-align: right;" href="#top-of-page" title="Top of the page" alt="Top of the page"><i class="fa fa-chevron-circle-up fa-2x"></i></a>
  </div><!-- /.small-12.columns -->
</div><!-- /.row -->

#### 2007

Wouters, BJ, Jorda, MA, Keeshan, K, et al. Distinct gene expression profiles of acute myeloid/T-lymphoid leukemia with silenced CEBPA and mutations in NOTCH1. 
Blood.

Weir, BA, Woo, MS, Getz, G, et al. Characterizing the cancer genome in lung adenocarcinoma. 
Nature.

Steidl, U, Steidl, C, Ebralidze, A, et al. A distal single nucleotide polymorphism alters long-range regulation of the PU.1 gene in acute myeloid leukemia. 
Journal of Clinical Investigation.

Bakker, WJ, van Dijk, TB, Parren-van Amelsvoort, M, et al. Differential regulation of Foxo3a target genes in erythropoiesis. 
Molecular Cellular Biology.

#### 2006

Verhaak, RG, Sanders, MA, Bijl, MA, et al. HeatMapper: powerful combined visualization of gene expression profile correlations, genotypes, phenotypes and sample characteristics. 
BMC Bioinformatics.

Erkeland, SJ, Verhaak, RG, Valk, PJ, et al. Significance of murine retroviral mutagenesis for identification of disease genes in human acute myeloid leukemia. Cancer Res 66, 622-626. 
Cancer Research.

Verhaak RG, Staal FJ, Valk PJ, et al. The effect of oligonucleotide microarray data pre-processing on the analysis of patient-cohort studies. 
BMC Bioinformatics.

Steidl U, Rosenbauer F, Verhaak RG, et al. Essential role of Jun family transcription factors in PU.1 knockdown-induced leukemic stem cells. 
Nature Genetics.

#### 2005

Verhaak RG, Goudswaard CS, van Putten W, et al.. Mutations in nucleophosmin (NPM1) in acute myeloid leukemia (AML): association with other gene abnormalities and previously established gene expression signatures and their favorable prognostic significance. 
Blood

#### 2004

Valk PJ, Verhaak RG, Beijen MA, et al. Prognostically useful gene-expression profiles in acute myeloid leukemia. 
New England Journal of Medicine.


